Martingale Asset Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-37,868
Closed -$276K 822
2023
Q3
$276K Sell
37,868
-21,068
-36% -$157K 0.01% 699
2023
Q2
$390K Buy
58,936
+36
+0.1% +$184 0.01% 657
2023
Q1
$201K Hold
58,900
﹤0.01% 781
2022
Q4
$164K Sell
58,900
-9
-0% -$27 ﹤0.01% 803
2022
Q3
$170K Hold
58,909
﹤0.01% 793
2022
Q2
$205K Sell
58,909
-45
-0.1% -$176 ﹤0.01% 805
2022
Q1
$278K Hold
58,954
﹤0.01% 740
2021
Q4
$357K Buy
58,954
+43,554
+283% +$302K ﹤0.01% 706
2021
Q3
$94K Buy
+15,400
New +$174K ﹤0.01% 837

Other funds holding MDXG

Martingale Asset Management's MDXG Position: Q4 2023 in Review

Martingale Asset Management sold out of MiMedx Group (MDXG) in Q4 2023, closing a stake of 37,868 shares — an estimated $276K sold.

Martingale Asset Management first reported a position in MDXG in Q3 2021 and held it in 9 quarters. The position peaked at $390K in Q2 2023. 199 funds tracked by Wall St. Rank hold MDXG as of Q4 2023.

  • Martingale Asset Management reported no remaining MiMedx Group position as of Q4 2023 after selling out during the quarter.
  • Martingale Asset Management sold 37,868 MiMedx Group shares in Q4 2023, an estimated $276K.
  • Martingale Asset Management first reported a position in MiMedx Group in Q3 2021 and held it in 9 quarters.
  • Martingale Asset Management's MiMedx Group position peaked at $390K in Q2 2023.
  • 199 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2023.

Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.